Daniel B. Kramer, Ph.D. - Publications

Affiliations: 
2005 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Forestry and Wildlife Agriculture, Environmental Sciences

84 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Yang S, Stabenau HF, Kiernan K, Diamond JE, Kramer DB. Clinical utility of remote monitoring for patients with cardiac implantable electrical devices. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. PMID 36327060 DOI: 10.1007/s10840-022-01406-7  0.301
2020 Holtzman JN, Kramer DB. Authors' reply to Costs and utilization of remote device monitoring in cardiology. Heart Rhythm. PMID 32750470 DOI: 10.1016/J.Hrthm.2020.07.034  0.31
2020 Wallace BC, Allen LA, Knoepke CE, Glasgow RE, Lewis CL, Fairclough DL, Helmkamp LJ, Fitzgerald MD, Tzou WS, Kramer DB, Varosy PD, Gupta SK, Mandrola JM, Brancato SC, Peterson PN, et al. A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data. American Heart Journal. 226: 161-173. PMID 32599257 DOI: 10.1016/J.Ahj.2020.04.010  0.371
2020 Holtzman JN, Wadhera RK, Choi E, Zhao T, Secemsky EA, Fraiche AM, Shen C, Kramer DB. Trends in Utilization and Spending on Remote Monitoring of Pacemakers and Implantable Cardioverter-Defibrillators among Medicare Beneficiaries. Heart Rhythm. PMID 32526349 DOI: 10.1016/J.Hrthm.2020.05.044  0.351
2020 Merchant FM, Levy WC, Kramer DB. Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use. Journal of the American Heart Association. 9: e015139. PMID 32089058 DOI: 10.1161/Jaha.119.015139  0.318
2020 McCarthy KJ, Locke AH, Coletti M, Young D, Merchant FM, Kramer DB. Outcomes Following Implantable Cardioverter-Defibrillator Generator Replacement in Adults: A Systematic Review. Heart Rhythm. PMID 31931173 DOI: 10.1016/J.Hrthm.2020.01.005  0.381
2019 Hu SY, Santus E, Forsyth AW, Malhotra D, Haimson J, Chatterjee NA, Kramer DB, Barzilay R, Tulsky JA, Lindvall C. Can machine learning improve patient selection for cardiac resynchronization therapy? Plos One. 14: e0222397. PMID 31581234 DOI: 10.1371/Journal.Pone.0222397  0.318
2019 Rajan PV, Holtzman JN, Kesselheim AS, Yeh RW, Kramer DB. Landscape of Cardiovascular Device Registries in the United States. Journal of the American Heart Association. 8: e012756. PMID 31433706 DOI: 10.1161/Jaha.119.012756  0.39
2019 Reeder HT, Shen C, Buxton AE, Haneuse SJ, Kramer DB. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators. Circulation. Cardiovascular Quality and Outcomes. 12: e005675. PMID 31412732 DOI: 10.1161/Circoutcomes.119.005675  0.339
2019 Steinhaus DA, Lubitz SA, Noseworthy PA, Kramer DB. Exercise Interventions in Patients With Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of Cardiopulmonary Rehabilitation and Prevention. PMID 31397767 DOI: 10.1097/Hcr.0000000000000389  0.35
2019 Kramer DB, Buxton AE, Zimetbaum PJ. Conversion, Compromise, and Conversation-Moving to a Sensible Middle When Addressing Implantable Cardioverter-Defibrillator Therapy-Reply. Jama Cardiology. PMID 31365023 DOI: 10.1001/Jamacardio.2019.2610  0.334
2019 Amin MM, Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Hodge DO, Frey RJ, Frederick NK, Cha YM, Brenes-Salazar J, Madhavan M. Association between the charlson comorbidity index and outcomes after icd generator replacement. Pacing and Clinical Electrophysiology : Pace. PMID 31355952 DOI: 10.1111/Pace.13762  0.325
2019 Knoepke CE, Allen LA, Kramer DB, Matlock DD. Medicare Mandates for Shared Decision Making in Cardiovascular Device Placement. Circulation. Cardiovascular Quality and Outcomes. 12: e004899. PMID 31266371 DOI: 10.1161/Circoutcomes.119.004899  0.31
2019 Stern AD, Gordon WJ, Landman AB, Kramer DB. Cybersecurity features of digital medical devices: an analysis of FDA product summaries. Bmj Open. 9: e025374. PMID 31256020 DOI: 10.1136/Bmjopen-2018-025374  0.314
2019 Kramer DB, Kesselheim AS. Trust and transparency in medical device regulation. Bmj (Clinical Research Ed.). 365: l4166. PMID 31213458 DOI: 10.1136/Bmj.L4166  0.313
2019 Kramer DB, Buxton AE, Zimetbaum PJ. Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt. Jama Cardiology. PMID 30994859 DOI: 10.1001/Jamacardio.2019.0882  0.329
2019 Rajan PV, Holtzman JN, Kesselheim AS, Yeh RW, Kramer DB. Abstract 235: Landscape of Cardiovascular Device Registries in the US Circulation-Cardiovascular Quality and Outcomes. 12. DOI: 10.1161/Hcq.12.Suppl_1.235  0.346
2019 Holtzman JN, Wadhera RK, Fraiche AM, Choi E, Shen C, Kramer DB. Abstract 234: Remote Monitoring Utilization and Medicare Spending for Pacemakers and Implantable Cardioverter-Defibrillators Circulation-Cardiovascular Quality and Outcomes. 12. DOI: 10.1161/Hcq.12.Suppl_1.234  0.344
2019 Holtzman JN, Wadhera RK, Fraiche AM, Choi E, Shen C, Kramer DB. Abstract 233: Geographic Variability in the Utilization of Remote Monitoring for Pacemakers and Implantable Cardioverter-Defibrillators Circulation-Cardiovascular Quality and Outcomes. 12. DOI: 10.1161/Hcq.12.Suppl_1.233  0.368
2019 Azim AA, Zimetbaum P, Kramer DB, Karchmer AW, Stead W. 2550. A Meeting of the Minds Over Matters of the Heart: Using Interdisciplinary Education to Build Consensus in Managing Cardiac Implantable Electronic Device (CIED) Infections Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.2228  0.352
2018 Kramer DB, Normand ST, Volya R, Hatfield LA. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator. Circulation. Cardiovascular Quality and Outcomes. 11: e004763. PMID 30562069 DOI: 10.1161/Circoutcomes.118.004763  0.385
2018 Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Noseworthy PA, Hodge DO, Lushinsky EC, Mulholland MB, Cha YM, Gersh BJ, Madhavan M. Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement. Circulation. Arrhythmia and Electrophysiology. 11: e006155. PMID 30354311 DOI: 10.1161/Circep.117.006155  0.384
2017 Stern AD, Kramer DB, Ouellet M, Kesselheim AS. Review times and adverse events for cardiovascular devices. Nature Biomedical Engineering. 1. PMID 31249727 DOI: 10.1038/S41551-016-0013  0.311
2017 Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ, Kramer DB, Lambrakos LK, Nasser NH, Sorajja D. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. PMID 29097318 DOI: 10.1016/J.Hrthm.2017.10.037  0.364
2017 Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ, Kramer DB, Lambrakos LK, Nasser NH, Sorajja D. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology. PMID 29097297 DOI: 10.1016/J.Jacc.2017.10.052  0.364
2017 Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ, Kramer DB, Lambrakos LK, Nasser NH, Sorajja D. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. PMID 29084732 DOI: 10.1161/Cir.0000000000000550  0.36
2017 Kramer DB, Fu K. Cybersecurity Concerns and Medical Devices: Lessons From a Pacemaker Advisory. Jama. PMID 29049709 DOI: 10.1001/Jama.2017.15692  0.33
2017 Kramer DB, Habtemariam D, Adjei-Poku Y, Samuel M, Engorn D, Reynolds MR, Mitchell SL. The Decisions, Interventions, and Goals in ImplaNtable Cardioverter-DefIbrillator TherapY (DIGNITY) Pilot Study. Journal of the American Heart Association. 6. PMID 28939708 DOI: 10.1161/Jaha.117.006881  0.379
2017 Basil A, Lubitz SA, Noseworthy PA, Reynolds MR, Gold H, Yassa D, Kramer D. Periprocedural Antibiotic Prophylaxis for Cardiac Implantable Electrical Device Procedures: Results From a Heart Rhythm Society Survey. Jacc. Clinical Electrophysiology. 3: 632-634. PMID 28804785 DOI: 10.1016/J.Jacep.2017.01.013  0.377
2017 Kramer DB, Yeh RW. Practical Improvements for Medical Device Evaluation. Jama. 318: 332-334. PMID 28742887 DOI: 10.1001/Jama.2017.8976  0.326
2017 Joynt KE, Kramer DB. Off-Label Use of High-Risk Cardiovascular Devices: Widening the Lens. Jama Cardiology. PMID 28636710 DOI: 10.1001/Jamacardio.2017.1732  0.305
2017 Ransford B, Kramer DB, Foo Kune D, Auto de Medeiros J, Yan C, Xu W, Crawford T, Fu K. Cybersecurity and medical devices: A Practical guide for cardiac electrophysiologists. Pacing and Clinical Electrophysiology : Pace. PMID 28512774 DOI: 10.1111/Pace.13102  0.353
2017 Strom JB, Whelan JB, Shen C, Zheng S, Mortele KJ, Kramer DB. The Safety and Utility of Magnetic Resonance Imaging on Patients with Cardiovascular Implantable Electronic Devices. Heart Rhythm. PMID 28385671 DOI: 10.1016/J.Hrthm.2017.03.039  0.35
2017 Yeh RW, Kramer DB. Decision Tools to Improve Personalized Care in Cardiovascular Disease: Moving the Art of Medicine Toward Science. Circulation. 135: 1097-1100. PMID 28320801 DOI: 10.1161/Circulationaha.116.024247  0.306
2017 Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL. Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry. Journal of the American Geriatrics Society. 65: 340-347. PMID 28198561 DOI: 10.1111/Jgs.14520  0.317
2017 Kramer DB, Tsai T, Natarajan P, Tewksbury E, Mitchell SL, Travison TG. Frailty, Physical Activity, and Mobility in Patients With Cardiac Implantable Electrical Devices. Journal of the American Heart Association. 6. PMID 28188253 DOI: 10.1161/Jaha.116.004659  0.389
2016 Kramer DB, Jones PW, Rogers T, Mitchell SL, Reynolds MR. Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 27702867 DOI: 10.1093/Europace/Euw267  0.358
2016 Hatfield LA, Kramer DB, Volya R, Reynolds MR, Normand SL. Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure. Journal of the American Heart Association. 5. PMID 27468928 DOI: 10.1161/Jaha.116.003532  0.39
2016 Cutlip DE, Kramer DB. Value-Based Hypothesis Testing for Cardiac Device Clinical Trials: A Pathway for Accelerated Reimbursement Decisions. Circulation. Cardiovascular Interventions. 9. PMID 27094322 DOI: 10.1161/Circinterventions.116.003627  0.378
2016 Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL. Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the NCDR®. Circulation. PMID 27016104 DOI: 10.1161/Circulationaha.115.020677  0.35
2016 Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circulation. Arrhythmia and Electrophysiology. 9: e003283. PMID 26921377 DOI: 10.1161/Circep.115.003283  0.379
2016 Kramer DB, Yeh RW, Zimetbaum PJ. Hard questions for mobile technology in cardiology. Trends in Cardiovascular Medicine. PMID 26919932 DOI: 10.1016/J.Tcm.2016.01.005  0.359
2015 Providência R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD. Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies. Journal of the American Heart Association. 4. PMID 26518666 DOI: 10.1161/Jaha.115.002418  0.358
2015 Kramer DB, Hatfield LA, Normand SL. Comparative effectiveness of cardiac implantable electrical devices. Heart (British Cardiac Society). 101: 1773-5. PMID 26303153 DOI: 10.1136/Heartjnl-2015-308295  0.421
2015 Kramer DB, Cutlip DE. Regulatory science: Trust and transparency in clinical trials of medical devices. Nature Reviews. Cardiology. 12: 503-4. PMID 26194550 DOI: 10.1038/Nrcardio.2015.112  0.354
2015 Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circulation. Cardiovascular Quality and Outcomes. 8: 437-46. PMID 26038525 DOI: 10.1161/Circoutcomes.114.001660  0.41
2015 Kramer DB, Hatfield LA, McGriff D, Ellis CR, Gura MT, Samuel M, Retel LK, Hauser RG. Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance. Journal of the American Heart Association. 4: e001672. PMID 26025935 DOI: 10.1161/Jaha.114.001672  0.4
2015 Kramer DB, Mitchell SL, Monteiro J, Jones PW, Normand SL, Hayes DL, Reynolds MR. Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study. Journal of the American Heart Association. 4. PMID 25979902 DOI: 10.1161/Jaha.115.001775  0.334
2015 Steinhaus DA, Waks JW, Collins R, Kleckner K, Kramer DB, Zimetbaum PJ. Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy. The American Journal of Cardiology. 116: 85-7. PMID 25933732 DOI: 10.1016/J.Amjcard.2015.03.047  0.337
2015 Levine YC, Tuttle MK, Rosenberg MA, Goldberg R, Matos J, Samuel M, Kramer DB, Buxton AE. Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines. The American Journal of Cardiology. 115: 1539-44. PMID 25840578 DOI: 10.1016/J.Amjcard.2015.02.056  0.398
2015 Kramer DB, Kesselheim AS. The Watchman saga--closure at last? The New England Journal of Medicine. 372: 994-5. PMID 25760353 DOI: 10.1056/Nejmp1415738  0.334
2015 Rajan PV, Kramer DB, Kesselheim AS. Medical device postapproval safety monitoring: where does the United States stand? Circulation. Cardiovascular Quality and Outcomes. 8: 124-31. PMID 25563662 DOI: 10.1161/Circoutcomes.114.001460  0.384
2014 Rome BN, Kramer DB, Kesselheim AS. Approval of high-risk medical devices in the US: implications for clinical cardiology. Current Cardiology Reports. 16: 489. PMID 24760423 DOI: 10.1007/S11886-014-0489-0  0.395
2014 Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 11: 216-21. PMID 24513917 DOI: 10.1016/J.Hrthm.2013.10.046  0.345
2014 Rome BN, Kramer DB, Kesselheim AS. FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012. Jama. 311: 385-91. PMID 24449317 DOI: 10.1001/Jama.2013.284986  0.384
2013 Kramer DB, Tan YT, Sato C, Kesselheim AS. Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China. Plos Medicine. 10: e1001519. PMID 24223035 DOI: 10.1371/Journal.Pmed.1001519  0.383
2013 Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circulation. Cardiovascular Quality and Outcomes. 6: 488-97. PMID 23759471 DOI: 10.1161/Circoutcomes.111.000054  0.368
2013 Kramer DB, Kesselheim AS. The medical device excise tax--over before it begins? The New England Journal of Medicine. 368: 1767-9. PMID 23614473 DOI: 10.1056/Nejmp1304175  0.315
2013 Kramer DB, Reynolds MR, Mitchell SL. Resynchronization: considering device-based cardiac therapy in older adults. Journal of the American Geriatrics Society. 61: 615-21. PMID 23581915 DOI: 10.1111/Jgs.12174  0.352
2013 Abdelhadi RH, Saba SF, Ellis CR, Mason PK, Kramer DB, Friedman PA, Gura MT, DiMarco JP, Mugglin AS, Reynolds MR, Bazaz RR, Retel LK, Hayes DL, Hauser RG. Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 10: 361-5. PMID 23128017 DOI: 10.1016/J.Hrthm.2012.10.045  0.335
2012 Kramer DB, Mitchell SL, Brock DW. Deactivation of pacemakers and implantable cardioverter-defibrillators. Progress in Cardiovascular Diseases. 55: 290-9. PMID 23217433 DOI: 10.1016/J.Pcad.2012.09.003  0.399
2012 Kramer DB, Xu S, Kesselheim AS. How does medical device regulation perform in the United States and the European union? A systematic review. Plos Medicine. 9: e1001276. PMID 22912563 DOI: 10.1371/Journal.Pmed.1001276  0.356
2012 Kramer DB, Baker M, Ransford B, Molina-Markham A, Stewart Q, Fu K, Reynolds MR. Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance. Plos One. 7: e40200. PMID 22829874 DOI: 10.1371/Journal.Pone.0040200  0.309
2012 Hauser RG, Mugglin AS, Friedman PA, Kramer DB, Kallinen L, McGriff D, Hayes DL. Early detection of an underperforming implantable cardiovascular device using an automated safety surveillance tool. Circulation. Cardiovascular Quality and Outcomes. 5: 189-96. PMID 22396584 DOI: 10.1161/Circoutcomes.111.962621  0.393
2012 Kramer DB, Xu S, Kesselheim AS. Regulation of medical devices in the United States and European Union. The New England Journal of Medicine. 366: 848-55. PMID 22332952 DOI: 10.1056/Nejmhle1113918  0.35
2012 Kramer DB, Buxton AE, Zimetbaum PJ. Time for a change--a new approach to ICD replacement. The New England Journal of Medicine. 366: 291-3. PMID 22276818 DOI: 10.1056/Nejmp1111467  0.355
2012 Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 9: 42-6. PMID 21893137 DOI: 10.1016/J.Hrthm.2011.08.031  0.318
2011 Kramer DB, Brock DW, Tedrow UB. Informed consent in cardiac resynchronization therapy: what should be said? Circulation. Cardiovascular Quality and Outcomes. 4: 573-7. PMID 21934080 DOI: 10.1161/Circoutcomes.111.961680  0.389
2011 Kramer DB, Ottenberg AL, Gerhardson S, Mueller LA, Kaufman SR, Koenig BA, Mueller PS. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. 32: 243-52. PMID 21805140 DOI: 10.1007/S10840-011-9596-7  0.355
2011 Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. The American Journal of Cardiology. 107: 1071-1075.e5. PMID 21296323 DOI: 10.1016/J.Amjcard.2010.11.036  0.431
2011 Kramer DB, Maisel WH. An unusual cause of abnormal intrathoracic impedance in a patient with arrhythmogenic right ventricular cardiomyopathy. Pacing and Clinical Electrophysiology : Pace. 34: e60-3. PMID 20456645 DOI: 10.1111/J.1540-8159.2010.02774.X  0.343
2011 Kramer DB, Josephson ME. Expanding the use of cardiac resynchronization therapy: Words of caution Cardiac Electrophysiology Clinics. 3: 529-537. DOI: 10.1016/J.Ccep.2011.07.001  0.415
2010 Kramer DB, Ottenberg AL, Mueller PS. Management of cardiac electrical implantable devices in patients nearing the end of life or requesting withdrawal of therapy: review of the Heart Rhythm Society 2010 consensus statement. Polskie Archiwum Medycyny Wewnä™Trznej. 120: 497-502. PMID 21178906 DOI: 10.20452/Pamw.1003  0.403
2010 Kramer DB, Josephson ME. Three questions for evidence-based cardiac electrophysiology. Circulation. Cardiovascular Quality and Outcomes. 3: 704-9. PMID 21081751 DOI: 10.1161/Circoutcomes.110.957381  0.371
2010 Kramer DB, Kesselheim AS, Brock DW, Maisel WH. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 7: 1537-42. PMID 20650332 DOI: 10.1016/J.Hrthm.2010.07.018  0.365
2010 Maisel WH, Kramer DB. Extracting guidance from extraction data. Journal of the American College of Cardiology. 56: 651-2. PMID 20598468 DOI: 10.1016/J.Jacc.2010.03.059  0.378
2010 Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R, et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 7: 1008-26. PMID 20471915 DOI: 10.1016/J.Hrthm.2010.04.033  0.374
2010 Lubitz SA, Leong-Sit P, Fine N, Kramer DB, Singh J, Ellinor PT. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. European Journal of Heart Failure. 12: 360-6. PMID 20335354 DOI: 10.1093/Eurjhf/Hfq029  0.325
2010 Kramer DB, Mallis E, Zuckerman BD, Zimmerman BA, Maisel WH. Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007. American Journal of Therapeutics. 17: 2-7. PMID 20038828 DOI: 10.1097/Mjt.0B013E3181Ca8105  0.361
2010 Kramer DB, Kesselheim AS, Brock DW, Maisel WH. Physician Ethical and Legal Views Regarding Deactivation of Cardiac Implantable Electrical Devices Journal of Cardiac Failure. 16. DOI: 10.1016/J.Cardfail.2010.06.371  0.391
2008 Maisel WH, Kramer DB. Implantable cardioverter-defibrillator lead performance. Circulation. 117: 2721-3. PMID 18506015 DOI: 10.1161/Circulationaha.108.776807  0.424
2006 Field ME, Solomon SD, Lewis EF, Kramer DB, Baughman KL, Stevenson LW, Tedrow UB. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. Journal of Cardiac Failure. 12: 616-20. PMID 17045180 DOI: 10.1016/J.Cardfail.2006.06.472  0.346
2006 Kramer DB, Polasky S, Starfield A, Palik B, Westphal L, Snyder S, Jakes P, Hudson R, Gustafson E. A comparison of alternative strategies for cost-effective water quality management in lakes. Environmental Management. 38: 411-25. PMID 16799845 DOI: 10.1007/S00267-005-0011-Y  0.482
2006 Tedrow UB, Kramer DB, Stevenson LW, Stevenson WG, Baughman KL, Epstein LM, Lewis EF. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy. The American Journal of Cardiology. 97: 1737-40. PMID 16765124 DOI: 10.1016/J.Amjcard.2006.01.033  0.32
Show low-probability matches.